SOURCE: OPTIMIZERx Corporation
ROCHESTER, MI--(Marketwire - Oct 16, 2012) - OPTIMIZERx Corp. (OTCBB: OPRX) DrFirst, the nation's leading e-prescribing and solutions platform provider, announced today the launch of Patient Advisorsm, a medication adherence solution that works within DrFirst's Rcopia e-prescribing platform, or any EMR or HIT solution. Patient Advisor is the result of strategic agreements between DrFirst and three leading medication adherence providers: KRAMES Staywell, SampleMD, and Adheris, Inc., an inVentiv Health Company. Patient Advisor is free for licensed providers.
"DrFirst's Patient Advisor provides physicians with instant access to patient-specific information, enabling them to quickly provide highly customized care and resources tailored to their patients' conditions. DrFirst's Patient Advisor is the first solution to combine evidence-based behavioral, clinical, and financial patient support resources and tools into a single platform within the EMR and e-prescribing workflow," says Chris Cresswell, general manager of Patient Innovations at DrFirst. "Physicians have a powerful new tool to better support patients between office visits."
The Patient Advisor platform provides physicians with a patient report card to gain insight into their patients' prescription fill rates. New functionality will also include changes in lab values, medication possession ratios, cross comparative analysis between fill rates and lab values, as well as other pertinent data. Early data already suggests this tool can improve medication adherence rates by more than 59%.
Each evidence-based tool that resides on the Patient Advisor platform is provided by the industry leader in its respective area of expertise. For example, Krames Staywell is the leader in supporting patients with education; SampleMD is the leading co-pay card vendor in the EMR channel; and Adheris is the leading and largest provider of direct-to-patient medication adherence programs. The strategic collaboration with these best-in-class partners also brings significant funding for these programs from more than 150 pharmaceutical brands.
"Realizing that patients need personalized support with management of their disease, our goal with Patient Advisor is first, to make it easy for physicians to access a patient report card in their workflow to identify those 'at-risk' and 'high-risk' patients that have a history of non-adherence, clinical care gaps or other important risk factors. The second part of the Patient Advisor goal is to empower physicians to support patients between office visits with financial, behavioral, and clinical resources tailored to their conditions, treatments, and self-management of disease," noted Cresswell.
Recognizing that many EMRs will want to bring some or all of these services to their physicians, DrFirst has designed the product to work either with its flagship Rcopia e-prescribing platform, or with any eRx, EMR or HIT platform.
"The industry needs a standard platform that integrates the very best of individual capabilities for seamless execution and consolidated reporting," comments G. Cameron Deemer, president of DrFirst. "This is clearly how we are differentiating our platform from other solutions that are tactic specific."
Founded in 2000, DrFirst is the nation's leading e-prescribing and solutions platform provider to physician practices, major health plans, health systems, hospitals, and EHR vendors. Through its Open Borders Program, DrFirst solutions integrate with over 250 EHR, practice management and HIT systems. A Surescripts Gold Certified solution provider for four consecutive years for its award-winning Rcopia electronic prescription management system, DrFirst utilizes the Surescripts network for pharmacy connectivity, health plan information and patient medication history. For more information, visit http://www.drfirst.com.
About SampleMD�OPTIMIZERx Corp
OPTIMIZERx Corp. (OTCBB: OPRX) provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. For more information, please go to www.optimizerxcorp.com or www.samplemd.com.
About Krames Staywell
Krames StayWell was established in 2011 when Krames Patient Education and StayWell Custom Communications united to become the largest provider of interactive, print and mobile patient education solutions, consumer health information, and population health management communications in the country. For more information, visit www.kramesstaywell.com.
About Adheris, Inc.
An inVentiv Health company, Adheris offers direct-to-patient programs that provide valuable medication education, timely prescription refill reminders and copay assistance. Adheris's programs are HIPAA compliant and are proven to influence positive behavior change for millions of patients on products across all major therapeutic classes. The Adheris pharmacy network includes more than 21,000 pharmacies, accounting for approximately 45% of all retail prescriptions. For more information, visit www.adheris.com.
About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. With 13,000 employees in 40 countries, inVentiv rapidly transforms promising ideas into commercial reality. inVentiv Health Inc. is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.